Logotype for Röko

Röko (RÖKO) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Röko

Q3 2025 earnings summary

5 Nov, 2025

Executive summary

  • Profit and organic growth lagged expectations due to sector-specific challenges and slower acquisition pace, with net sales up 6% to MSEK 4,776 and adjusted EBITA up 11% year-over-year, driven by acquisitions and margin improvements but offset by negative FX effects.

  • Net profit for YTD 2025 was MSEK 553, up from MSEK 534 in YTD 2024, though Q3 net profit declined 5% due to a prior year one-off gain.

  • The company completed two acquisitions in 2025, expanding the portfolio to 29 companies across multiple countries and sectors.

  • B shares were listed on Nasdaq Stockholm in March 2025, with share structure adjusted and transaction costs of MSEK 41 impacting profits.

Financial highlights

  • Adjusted EBITA rose from MSEK 889 to MSEK 983 year-over-year, with the margin improving from 20% to 21%.

  • Net sales increased from MSEK 4,513 to MSEK 4,776, with 3% organic growth in local currency and a -3% FX impact.

  • Free cash flow declined 6% year-to-date, but only 1% when adjusted for MSEK 41 IPO transaction costs; cash conversion was 68%, or 72% adjusted.

  • Return on capital employed improved to 14.5% from 13.8% year-over-year.

  • Interest-bearing net debt at MSEK 509, with financial net debt/EBITDA at 2.1x.

Outlook and guidance

  • Acquisition pipeline remains strong with many quality opportunities, but competition and high valuations have slowed deal completion.

  • Net Debt/EBITDA declined to 2.1x, reflecting strong cash generation and organic profit growth.

  • Mixed subsidiary performance, with weaker demand in construction, automotive, and US-exposed companies due to tariffs, but most expected to offset costs with price increases.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more